|
"lin m"的相關文件
顯示項目 101-109 / 109 (共5頁)
<< < 1 2 3 4 5
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
1995-12 |
Correlation of a missense mutation in the human Secretor alpha-1, 2-fucosyl-transferase gene with the Lewis (a+b+) phenotype: a potential molecular-basis for the weak Secretor allele (Se-w).
|
Yu, LC; Yang, YH; Broadberry, RE; Chen, YH; Chen, YS; Lin, M |
| 國立臺灣大學 |
1995-01 |
Effects of the benzodiazepine inverse agonist RO19-4603 on the maintenance of tolerance to a single dose of ethanol.
|
June, HL; Duemler, SE; Greene, TL; Williams, JA; Lin, M; Devaraju, SL; Chen, SHA; Lewis, MJ; Murphy, JM. |
| 臺大學術典藏 |
1995 |
Correlation of a missense mutation in the human Secretor α1,2-fucosyltransferase gene with the Lewis(a+b+) phenotype: A potential molecular basis for the weak Secretor allele (Se(w))
|
Yu L.-C.; Yang Y.-H.; Broadberry R.E.; Chen Y.-H.; Chan Y.-S.; Lin M.; LUNG-CHIH YU |
| 國立成功大學 |
1994-03 |
Cholangiographic CT in differential diagnosis of Caroli's disease and polycystic liver disease - a preliminary study
|
Hsu, P. I.; Lin, Xi-Zhang; Lin, Ching-Yih; Chang, Ting-Tsung; Shin, Jeng-Shiann; Huang, J. J.; Tsai, H. M.; Chen, K. H.; Chiu, N. T.; Lai, K. H.; Lin, M.; Yang, Y. F. |
| 中國醫藥大學 |
1994 |
VASODILATOR THERAPY IN CHRONIC AORTIC REGURGITATION - ENALAPRIL VERSUS HYDRALAZINE
|
LIN, M; CHIANG, HT; LIN, SL; CHIANG, BN; CHEITLIN, MD |
| 中國醫藥大學 |
1994 |
VASODILATOR THERAPY IN CHRONIC ASYMPTOMATIC AORTIC REGURGITATION - ENALAPRIL VERSUS HYDRALAZINE THERAPY
|
LIN, M; CHIANG, MT; LIN, SL; CHANG, MS; CHIANG, BN; KUO, HW; CHEITLIN, MD |
| 臺大學術典藏 |
1992 |
Nosocomial outbreak of scabies.
|
Lin M.;Liu J.C.;Hsieh B.L.;Hwang C.C.;Lin B.H.;PO-REN HSUEH; PO-REN HSUEH; Lin B.H.; Hwang C.C.; Hsieh B.L.; Liu J.C.; Lin M. |
| 臺大學術典藏 |
1992 |
Abscess formation complicated in ovarian mucinous cystadenoma: a case report.
|
Young C.; Lin M.; Yen K.P.; PO-REN HSUEH; Hwang C.C. |
| 國立臺灣大學 |
1976-11 |
Conceptual knowledge as related to language comprehension and recall.
|
Chang, C. M.; Lin, M. |
顯示項目 101-109 / 109 (共5頁)
<< < 1 2 3 4 5
每頁顯示[10|25|50]項目
|
